Are electronic signatures valid for consent?

Yes. Electronic signatures are generally valid under the ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted. Ensure intent, consent to electronic records, signer attribution, and reliable record retention to support legality.

How do we meet HIPAA requirements?

Use a vendor that permits a BAA, encrypts data in transit and at rest, and provides audited access logs. Maintain policies for minimum necessary disclosures and document patient authorization for uses beyond treatment, payment, and operations.

Can a minor provide consent electronically?

Minors generally cannot provide legally effective consent; obtain parental or guardian consent per state law. Some states recognize mature minor exceptions—consult institutional counsel and IRB for site-specific rules.

What if a participant refuses electronic signing?

Offer paper alternatives. ESIGN requires consumer-facing disclosures and an option to receive records on paper when requested. Document the participant's choice and provide a paper copy if they decline electronic records.

How is consent revoked or withdrawn?

Participants can withdraw at any time; document withdrawal in the record with date and scope. Withdrawal does not retroactively remove data already used in analyses unless the protocol or law requires otherwise.

What to do if a signature is disputed?

Preserve the full audit trail, authentication records, and access logs. Work with legal, IRB, and sponsor to investigate; stronger authentication methods reduce dispute risk.

Electronic Signature
Templates
Healthcare
Clinical Trial Consent Form

Clinical Trial Consent Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

CLINICAL TRIAL CONSENT FORM

Study Title: Principal Investigator:

Participant Information

Full Legal Name Date of Birth Gender Address

Phone

Email

Emergency Contact

Insurance Information

Insurance Provider

Policy Number

Group Number

Subscriber Name

Medical History

Current Medications Allergies Prior Surgeries / Hospitalizations Chronic Conditions

Study Description, Risks, Benefits, and Alternatives

Purpose and Procedures: I understand that the study involves procedures, tests, and clinic visits described in the study schedule. The principal procedures include:

Expected Duration: Participation is expected to last , including follow-up visits as required by the protocol.

Risks and Discomforts: The study may involve risks, side effects, or discomforts including but not limited to those described in the study information sheet. These risks may be serious and unpredictable. I have had the opportunity to discuss foreseeable risks with the research team.

Potential Benefits: Participation may provide medical information or direct benefit to me or a benefit to future patients; however, benefits cannot be guaranteed.

Alternatives: My alternative options include standard medical care or other treatments. I may choose not to participate and still receive usual care.

Confidentiality and Use of Data

Confidentiality: The research team will take reasonable steps to keep my study records private. My identity may be removed from records and data may be used in publications or shared with qualified researchers in coded form. Access to identifiable data will be limited to study staff, monitoring bodies, and regulatory authorities as required by law.

Storage and Future Use: I consent to the storage of my biological specimens and data for future research as described in the study information. I understand that future use may not require additional consent if data is de-identified.

Compensation and Medical Treatment for Injury

Compensation: I will be informed of any payments, travel reimbursement, or compensation for participation as specified by the study. Compensation for research-related injury is described in the study information; I understand the limits of compensation and my rights to seek medical care.

Voluntary Participation and Right to Withdraw

Voluntary Participation: My participation is voluntary. I may withdraw consent at any time without penalty or loss of benefits to which I am otherwise entitled. If I withdraw, the research team may retain and use data already collected unless I request otherwise in writing.

Participant Acknowledgment and Consent

By checking the boxes below, I acknowledge that the elements of informed consent listed have been explained to me and that I understand them.

I have received and read the study information and had the opportunity to ask questions that were answered to my satisfaction.

I understand that participation is voluntary and that I may withdraw at any time without penalty.

I understand the potential risks and benefits and accept the risks described.

HIPAA Authorization

I authorize the disclosure of my identifiable health information to the research team and authorized parties for purposes of conduct, oversight, and analysis of this research. This authorization includes medical records, laboratory results, and other study-related information as described in the study information.

I authorize the use and disclosure of my health information for the research described above.

Authorization Expiration Date

Contact Information

For questions about the study or study-related injury, contact:

For questions about subject rights or concerns, contact:

Optional Consent Items

I consent to storage of biological specimens for future research.

I consent to be recontacted for future studies related to this research.

Participant Name:

Signature:

Date:

If signed by legal representative, indicate relationship and authority:

Certification: By signing above I certify that I am the person named as the participant or that I am the legally authorized representative of the participant, that I have read and understand the information in this document, that my questions have been answered, and that I consent voluntarily to participate in this study.

What the Clinical Trial Consent Form Is

A Clinical Trial Consent Form documents a prospective participant's informed agreement to join a research study. It explains the study's purpose, procedures, foreseeable risks and benefits, alternatives, confidentiality protections, and compensation or costs. The form records voluntary consent, authorizes collection and use of health data, and provides contact information for questions and withdrawal. For U.S.-based trials it supports IRB review and regulatory compliance, and it typically accompanies participant screening, enrollment, and ongoing consent processes.

Why a Clear Consent Form Matters

A complete consent form protects participant rights, documents voluntary agreement, and helps sponsors and sites meet regulatory requirements such as FDA expectations and IRB oversight. It reduces legal risk, improves participant understanding, and creates an auditable record of consent for compliance with ESIGN, UETA, and HIPAA where applicable.

Who Prepares and Signs This Form

Clinical investigators, study coordinators, IRBs, and sponsors prepare and approve consent forms; participants or authorized representatives sign them.

Principal investigators and site study staff who draft, review, and present the consent language to participants.
Institutional Review Boards (IRBs) that review form content for ethical and regulatory adequacy.
Participants or legally authorized representatives who must sign to indicate informed consent.

Accurate completion and secure retention by sites and sponsors ensure valid consent, protect participants, and support inspection or audit requests.

Core Sections Every Professional Consent Form Should Include

A compliant Clinical Trial Consent Form is organized, plain-language, and specific about study details and participant rights.

Study Overview

Concise description of purpose, duration, and number of participants, written in non-technical language to support participant understanding and informed choice.

Procedures

Step-by-step list of tests, visits, sample collection, and participant responsibilities, including approximate time commitments and frequency.

Risks and Benefits

Clear summary of known and potential risks, discomforts, and expected benefits, including likelihood and severity where known.

Alternatives

Explanation of available treatment alternatives or options to decline participation without penalty to clinical care.

Privacy and Data Use

Details on how health data and biospecimens will be used, shared, de-identified, stored, and protected under HIPAA and institutional policies.

Authorization

Signature block with dated consent, witness or representative fields when required, and contact information for questions and withdrawal.

Step-by-Step: Completing the Consent Process

Follow these sequential steps to obtain valid, auditable consent for a clinical trial.

01

Confirm Eligibility: Verify inclusion/exclusion criteria before consent.
02

Provide the Form: Give the full consent document to the participant for review.
03

Discuss and Answer: Discuss risks, benefits, and alternatives; answer participant questions.
04

Sign and Record: Obtain signature, date, and provide participant a copy.

Configuring an Online Consent Workflow

Set up clear digital fields, strong authentication, and retention rules when completing consent forms electronically.

Field	Configuration
Authentication	Email link with optional SMS two-factor authentication
Required Fields	Make name, DOB, signature, and date mandatory
Auto-fill	Use verified patient data to prefill non-sensitive fields
Audit Trail	Enable IP, timestamp, and action logging

Secure eSubmission and Platform Needs

Choose a platform that supports HIPAA protections, robust audit trails, and file export in standard formats.

File Formats: PDF and DOCX support
Integrations: Connects with EHRs and cloud storage
Authentication: SMS, email, or enterprise SSO

Ensure the platform can retain signed records, produce certificates of completion, and meet institutional data retention and access requirements.

Typical Routing After Consent Is Obtained

After signing, the consent form should be routed to all required recipients and stored according to institutional policy.

IRB Record: Upload a copy to the IRB submission file
Sponsor Copy: Send to sponsor or CRO per protocol
Site File: Store in the site research file (locked)
Participant Copy: Provide participant a readable copy

Security and Compliance Essentials

HIPAA: BAA required for protected health information

Encryption: TLS 1.2/1.3 in transit; AES-256 at rest

21 CFR Part 11: Compliant options for FDA-regulated records

SOC 2: SOC 2 Type II certified controls

Audit Trail: Timestamps, IPs, and action history recorded

Accessibility: WCAG 2.0 Level AA support

Consequences of Incomplete or Invalid Consent

Regulatory Action: FDA or OHRP findings and enforcement

IRB Noncompliance: Suspension or protocol hold

Civil Liability: Claims for lack of informed consent

HIPAA Violation: Fines and corrective action

Data Exclusion: Participant data may be unusable in analysis

Reputational Harm: Loss of trust and future enrollment

Common Mistakes Sites Make

Presenting an outdated consent version, causing noncompliance with the approved protocol and IRB conditions.
Failing to obtain signature before study procedures begin, which can invalidate participant data and trigger corrective action.
Using insufficient authentication for electronic signatures without documented participant consent to electronic records and ESIGN disclosures.
Providing overly technical language that participants cannot reasonably understand, undermining informed consent.

Timing Rules and Important Deadlines

Observe precise timing requirements: consent must be obtained before study interventions and documented for audit readiness.

Initial Consent:

Obtain and document consent before any study-specific procedures

Protocol Amendments:

Re-consent participants for material changes within 30 days or per IRB instruction

Ongoing Consent:

Document any additional consents for new procedures or extended follow-up

Withdrawal:

Honor withdrawal requests immediately and document date and reason

Audit Availability:

Provide signed consents on request for sponsor or regulatory audits

Typical eSignature Pricing and Feature Snapshot

Compare starting prices and key capabilities for common eSignature providers; signNow is listed first per vendor comparison guidance.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies by vendor	Varies by vendor	Varies by vendor	Varies by vendor
Bulk Send	Yes (Business Premium)	Yes	Yes	Yes	Varies
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No cap	100 envelopes/user/year	Varies by plan	Varies by plan	Varies by plan

Real-World Use Cases Using Digital Consent

These examples show how clinical or healthcare organizations used digital signing to manage consent and compliance.

Fertility Centers of Illinois

Moved consent forms online to reduce turnaround and improve access for patients.

Faster patient onboarding and fewer missed signatures.
John Butler, Founder, said the platform and support helped the center meet compliance needs while enabling remote and mobile signing for patients.

Optica Ventures LLC

Streamlined signature workflows for research agreements and partner documents.

Reduced admin time across sites.
Brian Fitzgibbons, COO, described the interface as simple for staff and clients, improving document handling across the research lifecycle.

Frequently Asked Questions and Practical Answers

Answers to typical questions about enforceability, HIPAA, minors, and what to do if a signature is challenged.

Need help? Contact support

Are electronic signatures valid for consent?
Yes. Electronic signatures are generally valid under the ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted. Ensure intent, consent to electronic records, signer attribution, and reliable record retention to support legality.
How do we meet HIPAA requirements?
Use a vendor that permits a BAA, encrypts data in transit and at rest, and provides audited access logs. Maintain policies for minimum necessary disclosures and document patient authorization for uses beyond treatment, payment, and operations.
Can a minor provide consent electronically?
Minors generally cannot provide legally effective consent; obtain parental or guardian consent per state law. Some states recognize mature minor exceptions—consult institutional counsel and IRB for site-specific rules.
What if a participant refuses electronic signing?
Offer paper alternatives. ESIGN requires consumer-facing disclosures and an option to receive records on paper when requested. Document the participant's choice and provide a paper copy if they decline electronic records.
How is consent revoked or withdrawn?
Participants can withdraw at any time; document withdrawal in the record with date and scope. Withdrawal does not retroactively remove data already used in analyses unless the protocol or law requires otherwise.
What to do if a signature is disputed?
Preserve the full audit trail, authentication records, and access logs. Work with legal, IRB, and sponsor to investigate; stronger authentication methods reduce dispute risk.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now